Sino Biopharmaceutical Limited (FRA:SMZ1)

Sino Biopharmaceutical Statistics

Total Valuation

FRA:SMZ1 has a market cap or net worth of EUR 17.44 billion. The enterprise value is 17.99 billion.

Market Cap	17.44B
Enterprise Value	17.99B

Important Dates

The last earnings date was Monday, August 25, 2025.

Earnings Date	Aug 25, 2025
Ex-Dividend Date	Aug 29, 2025

Share Statistics

Current Share Class	17.88B
Shares Outstanding	n/a
Shares Change (YoY)	-2.10%
Shares Change (QoQ)	-0.85%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	8.81B

Valuation Ratios

The trailing PE ratio is 37.90 and the forward PE ratio is 32.98.

PE Ratio	37.90
Forward PE	32.98
PS Ratio	4.80
PB Ratio	3.21
P/TBV Ratio	4.85
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	39.09
EV / Sales	4.90
EV / EBITDA	21.82
EV / EBIT	26.23
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.36, with a Debt / Equity ratio of 0.26.

Current Ratio	1.36
Quick Ratio	1.14
Debt / Equity	0.26
Debt / EBITDA	1.73
Debt / FCF	n/a
Interest Coverage	21.69

Financial Efficiency

Return on equity (ROE) is 15.40% and return on invested capital (ROIC) is 6.55%.

Return on Equity (ROE)	15.40%
Return on Assets (ROA)	5.07%
Return on Invested Capital (ROIC)	6.55%
Return on Capital Employed (ROCE)	11.47%
Revenue Per Employee	157,581
Profits Per Employee	19,958
Employee Count	24,379
Asset Turnover	0.43
Inventory Turnover	2.83

Taxes

In the past 12 months, FRA:SMZ1 has paid 102.24 million in taxes.

Income Tax	102.24M
Effective Tax Rate	11.27%

Stock Price Statistics

The stock price has increased by +170.72% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+170.72%
50-Day Moving Average	0.79
200-Day Moving Average	0.52
Relative Strength Index (RSI)	64.88
Average Volume (20 Days)	18,693

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:SMZ1 had revenue of EUR 3.63 billion and earned 460.14 million in profits. Earnings per share was 0.03.

Revenue	3.63B
Gross Profit	2.97B
Operating Income	682.26M
Pretax Income	906.96M
Net Income	460.14M
EBITDA	819.68M
EBIT	682.26M
Earnings Per Share (EPS)	0.03

Balance Sheet

The company has 2.36 billion in cash and 1.42 billion in debt, giving a net cash position of 935.13 million.

Cash & Cash Equivalents	2.36B
Total Debt	1.42B
Net Cash	935.13M
Net Cash Per Share	n/a
Equity (Book Value)	5.44B
Book Value Per Share	0.22
Working Capital	1.07B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 81.77%, with operating and profit margins of 18.78% and 12.67%.

Gross Margin	81.77%
Operating Margin	18.78%
Pretax Margin	24.96%
Profit Margin	12.67%
EBITDA Margin	22.56%
EBIT Margin	18.78%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.01, which amounts to a dividend yield of 1.03%.

Dividend Per Share	0.01
Dividend Yield	1.03%
Dividend Growth (YoY)	40.37%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.10%
Shareholder Yield	3.12%
Earnings Yield	2.64%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 20, 2020. It was a forward split with a ratio of 1.5.

Last Split Date	Jul 20, 2020
Split Type	Forward
Split Ratio	1.5

Scores

Altman Z-Score	n/a
Piotroski F-Score	5